[11] |
郭晓燕,刘煜,林宏,等.中国Fisher综合征126例临床特点分析[J].中国神经免疫学和神经病学杂志,2011,18(5):321-324.
|
[16] |
桂千,程庆璋.吉兰-巴雷综合征18例临床分析[J].中国血液流变学杂志,2017,27(2):7-8.
|
[17] |
李玉荣,付学锋.1例双侧面瘫伴病理征阳性的吉兰-巴雷综合症的诊治体会[J].甘肃医药,2014,(11):880-881.
|
[1] |
中国吉兰-巴雷综合征诊治指南[C].2011年全国神经肌肉病年会暨炎性脱髓鞘性周围神经病与包涵体肌炎(病)诊治新进展学术研讨会论文集.2011:16-20.
|
[2] |
张红鸭,史明,裴瑞,等.老年动眼神经麻痹56例临床分析[J].疑难病杂志,2017,16(2):186-188.
|
[3] |
Wakerley BR,Uncini A,Yuki N.Guillain-Barré and Miller Fisher syndromes-new diagnostic classification[J].Nat Rev Neurol,2014,10(9):537-544.
|
[4] |
李海峰.Guillain-Barre综合征和M iller Fisher综合征的新诊断分类和标准[J].中国神经免疫学和神经病学杂志,2014,21(6):441-443.
|
[5] |
Lo YL.Clinical and immunological spectrum of the Miller Fisher syndrome[J].Muscle Nerve,2007,36 (5):615-627.
|
[7] |
Asbury AK,Arnason BG,Karp HR.Criteria for diagnosis of Guillain-Barré syndrome[J].Ann Neuro,1978,3(6):565-566.
|
[10] |
邢燕蒙,刘沛东,张保朝,等.M iller-Fisher综合征临床特点及亚型诊断(附27例报告)[J].中国神经免疫学和神经病学杂志,2016, 23(3):203-206.
|
[6] |
Kwok HM,sui HL,Wong WY,et al.Variants,clinical characteristics and prognostic factors of Guillain-Barré syndrome in Chinese[J].Universitas Psychologica,2007,6(3):623-636.
|
[8] |
Van-der-Meche FG,Van-Doorn PA,Meulstee J,et al.Diagnostic and classification criteria for the Guilain-Barré syndrome[J].Eur Neurol,2001,45(3):133-139.
|
[9] |
Sejvar JJ,Kohl KS,Gidudu J,et al.Guillain-Barré syndrome and Fisher syndrome:case definitions and guidelines for collection,analysis,and presentation of immunization safety data[J].Vaccine,2011,29(3):599-612.
|
[12] |
Takahashi M,Koga M,Yokoyama K.Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barre and Fisher syndromes in Japan[J].J Clin Microbiol,2005,43(1):335-339.
|
[13] |
Lolekha P,Phanthumchinda K.Miller-Fisher syndrome at King Chulalongkorn Memorial Hospital[J].J Med Assoc Thai,2009,92(4):471-477.
|
[14] |
Tomita M,Watanabe H,Morozumi H,et al.Pyramidal tract involvement in Guillain-Barré syndrome associated with anti-GM1 antibody[J].J Neurol Neurosurg Psychiatry,2010,81(5):583-585.
|
[15] |
Sharma B,Nagpal K,Handa R,et al.Combination of AIDP and pyramidal signs associated with antecede-nt hepatitis A infection: a rare (co)occurrence[J].BMJ Case Rep,2013,12(16):12-23.
|
[18] |
Kuwabara S,Mori M,Ogawara K,et al.Indicators of rapid clinical recovery in Guillain-Barre syndrome[J].J Neurol Neurosurg Psychiatr,2001,70(4):560-562.
|
[19] |
Schwerer B,Lassmann H,Kitz K,et al.Ganglioside GM1,a molecular target for immunological and toxic attacks:similarity of neuropathological lesions induced by gangliosideantiserum and cholera toxin[J].Acta Neuropathol,1986,72(1):55-61.
|
[20] |
Kuwabara S,Ogawara K,Koga M,et al.Hyperreflexia in Guillain-Barre syndrome:relation with acute motor axonal neuropathy and anti-GM1 antibody[J].J Neurol Neurosurg Psychiatr,1999,67(2):180-184.
|